Literature DB >> 1718835

The role of capillarization in hepatic failure: studies in carbon tetrachloride-induced cirrhosis.

A Martinez-Hernandez1, J Martinez.   

Abstract

During the cirrhotic process, the hepatic microvascular phenotype is transformed from sinusoids (discontinuous capillaries) into continuous capillaries. This transformation has been termed capillarization. Many hepatic functions depend on the rapid, bidirectional exchange of macromolecules between plasma and hepatocytes. To determine whether capillarization contributes to hepatic failure in cirrhosis, we decided to study the plasma clearance (125I) and hepatocyte uptake (electron microscopy) of three tracers in normal and cirrhotic rats. The tracers chosen were a hemeundecapeptide with peroxidatic activity (fluid-phase pinocytosis), asialofetuin (receptor-mediated endocytosis of a medium size protein) and ferritin (receptor-mediated endocytosis of a large size protein). The results demonstrate a decreased hepatocyte uptake of hemeundecapeptide; a significant delay in plasma clearance of asialofetuin; and a minor delay in plasma clearance of ferritin, but a striking trapping of ferritin in the cirrhotic capillary basement membrane. The delayed plasma clearance in cirrhosis cannot be ascribed to a decreased number of surface receptors because, in isolated hepatocytes, the number of molecules bound per cell was equivalent in normal and cirrhotic livers. These findings support the concept of capillarization, with the formation of continuous diffusion and filtration barriers between plasma and hepatocytes, representing a significant hindrance to the bidirectional macromolecular exchange normally taking place between these two compartments. Furthermore, at least in the case of ferritin, the capillary basement membrane of cirrhotic livers seems to be the major filtration barrier. This hindrance to hepatocyte uptake, and presumably also to secretion, may be the cause (or at least a major determinant) of the hepatic failure characteristic of cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718835     DOI: 10.1002/hep.1840140519

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  26 in total

1.  Programmed death-ligand 1 expression is an unfavorable prognostic factor of hepatocellular carcinoma after archiving sustained virologic response for hepatitis C virus infection.

Authors:  Reiichiro Kondo; Jun Akiba; Sachiko Ogasawara; Osamu Nakashima; Yoshiki Naito; Hironori Kusano; Yutaro Mihara; Masahiko Tanigawa; Hirohisa Yano
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

2.  Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis.

Authors:  H Muro; H Shirasawa; I Kosugi; S Nakamura
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

3.  Lymph vessel expansion and function in the development of hepatic fibrosis and cirrhosis.

Authors:  B Vollmar; B Wolf; S Siegmund; A D Katsen; M D Menger
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

4.  Liver metabolic zonation and hepatic microcirculation in carbon tetrachloride-induced experimental cirrhosis.

Authors:  E Gaudio; P Onori; A Franchitto; R Sferra; O Riggio
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

5.  Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.

Authors:  A E Muñoz; C Miguez; M Rubio; M Bartellini; D Levi; A Podestá; V Niselman; R Terg
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

6.  The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis.

Authors:  Liping Liu; Govardhana Rao Yannam; Taichiro Nishikawa; Toshiyuki Yamamoto; Hesham Basma; Ryotaro Ito; Masaki Nagaya; Joyeeta Dutta-Moscato; Donna B Stolz; Fenghai Duan; Klaus H Kaestner; Yoram Vodovotz; Alejandro Soto-Gutierrez; Ira J Fox
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

7.  Functional liver imaging with asialoglycoprotein receptors and serum hyaluronate in a patient with amyloidosis.

Authors:  O Hashimoto; M Harada; M Sata; K Imamura; N Matsukuma; H Fukushima; S Itano; M Ohishi; T Ueno; A Iemura
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

Review 8.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10

9.  Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosis.

Authors:  Balakrishnan Chakrapani Narmada; Yuzhan Kang; Lakshmi Venkatraman; Qiwen Peng; Rashidah Binte Sakban; Bramasta Nugraha; Xuan Jiang; Ralph M Bunte; Peter T C So; Lisa Tucker-Kellogg; Hai-Quan Mao; Hanry Yu
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

Review 10.  The hepatic extracellular matrix. II. Ontogenesis, regeneration and cirrhosis.

Authors:  A Martinez-Hernandez; P S Amenta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.